Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Mar 15, 2026; 18(3): 115505
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.115505
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.115505
Figure 4 Mechanism study on Yiqi Wenyang Jiedu prescription intervening in disulfidptosis of MKN45 gastric cancer cells.
A: Effect of Yiqi Wenyang Jiedu prescription (YWJP) on the expression of SLC7A11 and GLUT1 in MKN45 cells in HAase environment; B: Effect of YWJP on the NADP+/NADPH ratio in MKN45 cells in HAase environment; C: Effect of YWJP on the expression of CYFIP1, Rac1, ARP2, and ARP3 in MKN45 cells in HAase environment; D: Effect of YWJP on the disulfide bond level in MKN45 cells in HAase environment; E: Effect of YWJP on PI staining of MKN45 cells. aP < 0.05, bP < 0.01, NS: Not significant. Error bars represent the standard error of the data. CAF: Cancer-associated fibroblasts; YWJP: Yiqi Wenyang Jiedu prescription; BS: Blank serum.
- Citation: Kuang ZY, Qin XY, Wang XM, Song XT, Zhu XY, Li J. Yiqi Wenyang Jiedu prescription promotes disulfidptosis of gastric cancer by reversing senescent cancer-associated fibroblasts. World J Gastrointest Oncol 2026; 18(3): 115505
- URL: https://www.wjgnet.com/1948-5204/full/v18/i3/115505.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i3.115505